Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IERDL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
JP2025500952A ADC-1
|
|||||
| Synonyms |
ADC-1
Click to Show/Hide
|
|||||
| Organization |
Shanghai Hengrui Pharmaceutical Co Ltd, Jiangsu Hengrui Pharmaceutical Co Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.73-4.27
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
WO2023173026A 8-6
|
Payload Info | ||||
| Linker Name |
JP2025500952A-ADC-1-Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
JP2025500952A-ADC-1-Linker-8-6
|
|||||